Airway hydration and COPD

Cellular and Molecular Life Sciences

Volumn 72, Issue 19, 2015, Pages 3637-3652

  Ghosh, Arunava ^a   Boucher, R C ^a   Tarran, Robert ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Airway surface liquid; CFTR; Cystic fibrosis; ENaC; Mucus; Tobacco smoke

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ION CHANNEL; TOBACCO SMOKE; CFTR PROTEIN, HUMAN; SODIUM CHANNEL;

AIRWAY; AIRWAY HYDRATION; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CILIARY MOTILITY; CILIATED EPITHELIUM CELL; CYSTIC FIBROSIS; DEHYDRATION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MODEL; GOBLET CELL; HUMAN; HYDRATION; INNATE IMMUNITY; MORTALITY; MUCOCILIARY CLEARANCE; MUCUS SECRETION; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; ADVERSE EFFECTS; BIOLOGICAL MODEL; LUNG EXTRAVASCULAR FLUID; METABOLISM; PHYSIOLOGY; SMOKING;

BRONCHITIS, CHRONIC; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EXTRAVASCULAR LUNG WATER; HUMANS; MODELS, BIOLOGICAL; MUCOCILIARY CLEARANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SODIUM CHANNELS;

EID: 84941423127     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-015-1946-7     Document Type: Review

References (240)

1. Mathers CD, Loncar D (2011) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3(11): e442. doi: 10.1371/journal.pmed.0030442
2. Barnes PJ (2014) Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med 35(1):71-86
3. DeMeo DL, Silverman EK (2004) Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax 59(3):259-264
4. Kim V, Criner GJ (2012) Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187(3):228-237
5. Hogg JC et al (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350(26):2645-2653
6. Tsui LC (1992) The spectrum of cystic fibrosis mutations. Trends Genet 8(11):392-398
7. Harris A, Argent BE (1993) The cystic fibrosis gene and its product CFTR. Semin Cell Biol 4(1):37-44
8. Chmiel JF, Davis PB (2003) State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection? Respir Res 4:8
9. Collawn JF, Matalon S (2014) CFTR and lung homeostasis. Am J Physiol Lung Cell Mol Physiol 307(12):L917-L923
10. Rab A et al (2013) Cigarette smoke and CFTR: implications in the pathogenesis of COPD. Am J Physiol Lung Cell Mol Physiol 305(8):L530-L541
11. Chambers LA, Rollins BM, Tarran R (2007) Liquid movement across the surface epithelium of large airways. Respir Physiol Neurobiol 159(3):256-270
12. Ehre C, Ridley C, Thornton DJ (2014) Cystic fibrosis: an inherited disease affecting mucin-producing organs. Int J Biochem Cell Biol 52:136-145
13. Boucher RC (2004) Relationship of airway epithelial ion transport to chronic bronchitis. Proc Am Thorac Soc 1(1):66-70
14. Clunes LA et al (2012) Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration. FASEB J 26(2):533-545
15. Lundback B et al (2003) Not 15 but 50% of smokers develop COPD? - report from the obstructive lung disease in Northern Sweden studies. Respir Med 97(2):115-122
16. Mannino DM et al (2002) Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. Respir Care 47(10):1184-1199
17. Peacock JL et al (2011) Outdoor air pollution and respiratory health in patients with COPD. Thorax 66(7):591-596
18. Sunyer J (2001) Urban air pollution and chronic obstructive pulmonary disease: a review. Eur Respir J 17(5):1024-1033
19. Kurmi OP et al (2010) COPD and chronic bronchitis risk of indoor air pollution from solid fuel: a systematic review and meta-analysis. Thorax 65(3):221-228
20. Schikowski T et al (2013) Ambient air pollution: a cause of COPD? Eur Respir J 43(1):250-263
21. Mannino DM, Buist AS (2007) Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370(9589):765-773
22. Salvi SS, Barnes PJ (2009) Chronic obstructive pulmonary disease in non-smokers. Lancet 374(9691):733-743
23. Laurell CB, Eriksson S (2013) The electrophoretic alpha1-globulin pattern of serum in alpha1-antitrypsin deficiency. 1963. COPD 10(Suppl 1):3-8
24. Zorzetto M et al (2008) SERPINA1 gene variants in individuals from the general population with reduced alpha1-antitrypsin concentrations. Clin Chem 54(8):1331-1338
25. Stoller JK, Aboussouan LS (2005) Alpha1-antitrypsin deficiency. Lancet 365(9478):2225-2236
26. Cox DW, Levison H (1988) Emphysema of early onset associated with a complete deficiency of alpha-1-antitrypsin (null homozygotes). Am Rev Respir Dis 137(2):371-375
27. Brantly ML et al (1988) Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 138(2):327-336
28. Dowson LJ, Guest PJ, Stockley RA (2001) Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline. Am J Respir Crit Care Med 164(10 Pt 1):1805-1809
29. Boucher RC (2007) Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu Rev Med 58:157-170
30. Mall MA, Hartl D (2014) CFTR: cystic fibrosis and beyond. Eur Respir J 44(4):1042-1054
31. Smith A (1997) Pathogenesis of bacterial bronchitis in cystic fibrosis. Pediatr Infect Dis J 16(1):91-95 (discussion 95-96, 123-126)
32. Maestrelli P et al (2001) Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164(10):S76-S80
33. Thompson AB et al (1989) Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am Rev Respir Dis 140(6):1527-1537
34. Worlitzsch D et al (2002) Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109(3):317-325
35. Hogg JC (2004) Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364(9435):709-721
36. Hogg JC, Macklem PT, Thurlbeck WM (1968) Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 278(25):1355-1360
37. Knowles MR, Boucher RC (2002) Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 109(5):571-577
38. Antunes MB, Cohen NA (2007) Mucociliary clearance - a critical upper airway host defense mechanism and methods of assessment. Curr Opin Allergy Clin Immunol 7(1):5-10
39. Ali M et al (2011) Analysis of the proteome of human airway epithelial secretions. Proteome Sci 9:4
40. Pennington JE (1984) Respiratory tract infections: intrinsic risk factors. Am J Med 76(5A):34-41
41. Rogan MP et al (2006) Antimicrobial proteins and polypeptides in pulmonary innate defence. Respir Res 7:29
42. Puchelle E et al (2006) Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease. Proc Am Thorac Soc 3(8):726-733
43. Thornton DJ, Rousseau K, McGuckin MA (2008) Structure and function of the polymeric mucins in airways mucus. Annu Rev Physiol 70:459-486
44. Randell SH, Boucher RC (2006) Effective mucus clearance is essential for respiratory health. Am J Respir Cell Mol Biol 35(1):20-28
45. Fahy JV, Dickey BF (2010) Airway mucus function and dysfunction. N Engl J Med 363(23):2233-2247
46. Nadel JA, Davis B, Phipps RJ (1979) Control of mucus secretion and ion transport in airways. Annu Rev Physiol 41:369-381
47. Tarran R et al (2001) The relative roles of passive surface forces and active ion transport in the modulation of airway surface liquid volume and composition. J Gen Physiol 118(2):223-236
48. Tarran R et al (2001) The CF salt controversy: in vivo observations and therapeutic approaches. Mol Cell 8(1):149-158
49. Kilburn KH (1967) Cilia and mucus transport as determinants of the response of lung to air pollutants. Arch Environ Health 14(1):77-91
50. Schlesinger RB (1990) The interaction of inhaled toxicants with respiratory tract clearance mechanisms. Crit Rev Toxicol 20(4):257-286
51. Cone RA (2009) Barrier properties of mucus. Adv Drug Deliv Rev 61(2):75-85
52. Grotberg JB (2001) Respiratory fluid mechanics and transport processes. Annu Rev Biomed Eng 3:421-457
53. Tarran R, Button B, Boucher RC (2006) Regulation of normal and cystic fibrosis airway surface liquid volume by phasic shear stress. Annu Rev Physiol 68:543-561
54. Button B et al (2012) A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia. Science 337(6097):937-941
55. Cao R et al (2012) Mapping the protein domain structures of the respiratory mucins: a mucin proteome coverage study. J Proteome Res 11(8):4013-4023
56. Kesimer M et al (2013) Molecular organization of the mucins and glycocalyx underlying mucus transport over mucosal surfaces of the airways. Mucosal Immunol 6(2):379-392
57. Henderson AG et al (2014) Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure. J Clin Invest 124(7):3047-3060
58. Prescott E, Lange P, Vestbo J (1995) Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J 8(8):1333-1338
59. Rogers DF (1994) Airway goblet cells: responsive and adaptable front-line defenders. Eur Respir J 7(9):1690-1706
60. Cohn L (2006) Mucus in chronic airway diseases: sorting out the sticky details. J Clin Invest 116(2):306-308
61. Tyner JW et al (2006) Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. J Clin Invest 116(2):309-321
62. Atherton H et al (2003) Preliminary pharmacological characterisation of an interleukin-13-enhanced calcium-activated chloride conductance in the human airway epithelium. Naunyn Schmiedebergs Arch Pharmacol 367(2):214-217
63. Roy MG et al (2014) Muc5b is required for airway defence. Nature 505(7483):412-416
64. Hollingsworth MA, Swanson BJ (2004) Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 4(1):45-60
65. Davis CW, Dickey BF (2008) Regulated airway goblet cell mucin secretion. Annu Rev Physiol 70:487-512
66. Forstner G (1995) Signal transduction, packaging and secretion of mucins. Annu Rev Physiol 57:585-605
67. Hattrup CL, Gendler SJ (2008) Structure and function of the cell surface (tethered) mucins. Annu Rev Physiol 70:431-457
68. Rose MC, Voynow JA (2006) Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 86(1):245-278
69. Abdullah LH et al (1996) P2u purinoceptor regulation of mucin secretion in SPOC1 cells, a goblet cell line from the airways. Biochem J 316(Pt 3):943-951
70. 2+ activation of mucin secretion in airway goblet cells. Am J Physiol 273(1 Pt 1):L201-L210
71. 3(-) transport in mucin secretion: lessons from cystic fibrosis. Am J Physiol Cell Physiol 299(6):C1222-C1233
72. Verdugo P (1990) Goblet cells secretion and mucogenesis. Annu Rev Physiol 52:157-176
73. Livraghi A, Randell SH (2007) Cystic fibrosis and other respiratory diseases of impaired mucus clearance. Toxicol Pathol 35(1):116-129
74. Vladar EK, Antic D, Axelrod JD (2009) Planar cell polarity signaling: the developing cell's compass. Cold Spring Harb Perspect Biol 1(3):a002964
75. You Y et al (2004) Role of f-box factor foxj1 in differentiation of ciliated airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 286(4):L650-L657
76. Gomperts BN, Gong-Cooper X, Hackett BP (2004) Foxj1 regulates basal body anchoring to the cytoskeleton of ciliated pulmonary epithelial cells. J Cell Sci 117(Pt 8):1329-1337
77. Ostrowski LE et al (2002) A proteomic analysis of human cilia: identification of novel components. Mol Cell Proteomics 1(6):451-465
78. Satir P, Christensen ST (2007) Overview of structure and function of mammalian cilia. Annu Rev Physiol 69:377-400
79. Davis CW, Lazarowski E (2008) Coupling of airway ciliary activity and mucin secretion to mechanical stresses by purinergic signaling. Respir Physiol Neurobiol 163(1-3):208-213
80. Hayashi T et al (2005) ATP regulation of ciliary beat frequency in rat tracheal and distal airway epithelium. Exp Physiol 90(4):535-544
81. Korngreen A, Priel Z (1996) Purinergic stimulation of rabbit ciliated airway epithelia: control by multiple calcium sources. J Physiol 497(Pt 1):53-66
82. Lazarowski ER, Boucher RC (2009) Purinergic receptors in airway epithelia. Curr Opin Pharmacol 9(3):262-267
83. Lieb T et al (2002) Prolonged increase in ciliary beat frequency after short-term purinergic stimulation in human airway epithelial cells. J Physiol 538(Pt 2):633-646
84. Jain B et al (1993) Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun 191(1):83-88
85. Jiao J et al (2011) Regulation of ciliary beat frequency by the nitric oxide signaling pathway in mouse nasal and tracheal epithelial cells. Exp Cell Res 317(17):2548-2553
86. Li D et al (2000) Regulation of ciliary beat frequency by the nitric oxide-cyclic guanosine monophosphate signaling pathway in rat airway epithelial cells. Am J Respir Cell Mol Biol 23(2):175-181
87. Yang B, Schlosser RJ, McCaffrey TV (1996) Dual signal transduction mechanisms modulate ciliary beat frequency in upper airway epithelium. Am J Physiol 270(5 Pt 1):L745-L751
88. Schmid A et al (2011) Nucleotide-mediated airway clearance. Subcell Biochem 55:95-138
89. Salathe M (2007) Regulation of mammalian ciliary beating. Annu Rev Physiol 69:401-422
90. Wyatt TA et al (2010) Sequential activation of protein kinase C isoforms by organic dust is mediated by tumor necrosis factor. Am J Respir Cell Mol Biol 42(6):706-715
91. Frizzell RA (1988) Role of absorptive and secretory processes in hydration of the airway surface. Am Rev Respir Dis 138(6 Pt 2):S3-S6
92. Donaldson SH, Boucher RC (2007) Sodium channels and cystic fibrosis. Chest 132(5):1631-1636
93. Thibodeau PH, Butterworth MB (2013) Proteases, cystic fibrosis and the epithelial sodium channel (ENaC). Cell Tissue Res 351(2):309-323
94. Com G, Clancy JP (2009) Adenosine receptors, cystic fibrosis, and airway hydration. Handb Exp Pharmacol 193:363-381
95. Blouquit-Laye S, Chinet T (2007) Ion and liquid transport across the bronchiolar epithelium. Respir Physiol Neurobiol 159(3):278-282
96. - channels. Compr Physiol 1(4):2155-2174
97. Riordan JR (2005) Assembly of functional CFTR chloride channels. Annu Rev Physiol 67:701-718
98. Bear CE et al (1992) Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 68(4):809-818
99. - channel in CHO cells stably expressing the cystic fibrosis gene. Nature 352(6336):628-631
100. Gray MA, Greenwell JR, Argent BE (1988) Secretin-regulated chloride channel on the apical plasma membrane of pancreatic duct cells. J Membr Biol 105(2):131-142
101. Cheng SH et al (1991) Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. Cell 66(5):1027-1036
102. Hollenstein K, Dawson RJ, Locher KP (2007) Structure and mechanism of ABC transporter proteins. Curr Opin Struct Biol 17(4):412-418
103. + channel is made of three homologous subunits. Nature 367(6462):463-467
104. Jasti J et al (2007) Structure of acid-sensing ion channel 1 at 1.9 A resolution and low pH. Nature 449(7160):316-323
105. + channel involves proteolytic processing of the alpha- and gamma-subunits. J Biol Chem 278(39):37073-37082
106. Kleyman TR, Carattino MD, Hughey RP (2009) ENaC at the cutting edge: regulation of epithelial sodium channels by proteases. J Biol Chem 284(31):20447-20451
107. + channel (ENaC) by ubiquitination. The EMBO Journal 16(21):6325-6336
108. Kimura T et al (2011) Deletion of the ubiquitin ligase Nedd4L in lung epithelia causes cystic fibrosis-like disease. Proc Natl Acad Sci USA 108(8):3216-3221
109. Guggino WB (1999) Cystic fibrosis and the salt controversy. Cell 96(5):607-610
110. Hobbs CA, Da Tan C, Tarran R (2013) Does epithelial sodium channel hyperactivity contribute to cystic fibrosis lung disease? J Physiol 591(Pt 18):4377-4387
111. Horisberger JD (2003) ENaC-CFTR interactions: the role of electrical coupling of ion fluxes explored in an epithelial cell model. Pflugers Arch 445(4):522-528
112. Boucher RC (1994) Human airway ion transport. Part one. Am J Respir Crit Care Med 150(1):271-281
113. Knowles MR et al (1997) Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects. J Clin Invest 100(10):2588-2595
114. Coakley RD, Boucher RC (2001) Regulation and functional significance of airway surface liquid pH. Jop 2(4 Suppl):294-300
115. Garcia-Caballero A et al (2009) SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage. Proc Natl Acad Sci USA 106(27):11412-11417
116. Lazarowski ER et al (2004) Nucleotide release provides a mechanism for airway surface liquid homeostasis. J Biol Chem 279(35):36855-36864
117. Button B et al (2013) Mechanosensitive ATP release maintains proper mucus hydration of airways. Sci Signa 6(279):ra46
118. Button B, Boucher RC (2008) Role of mechanical stress in regulating airway surface hydration and mucus clearance rates. Respir Physiol Neurobiol 163(1-3):189-201
119. + channel and airway surface liquid volume by serine proteases. Pflugers Arch 460(1):1-17
120. Matsui H et al (1998) Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95(7):1005-1015
121. + transport via hydrolysis of PIP2. FASEB J 19(1):142-143
122. Pochynyuk O, Bugaj V, Stockand JD (2008) Physiologic regulation of the epithelial sodium channel by phosphatidylinositides. Curr Opin Nephrol Hypertens 17(5):533-540
123. Yue G, Malik B, Eaton DC (2002) Phosphatidylinositol 4,5-bisphosphate (PIP2) stimulates epithelial sodium channel activity in A6 cells. J Biol Chem 277(14):11965-11969
124. Hobbs CA et al (2013) Identification of SPLUNC1's ENaC-Inhibitory Domain Yields Novel Strategies to Treat Sodium Hyperabsorption in Cystic Fibrosis Airway Cultures. Am J Physiol Lung Cell Mol Physiol
125. Rollins BM et al (2010) SPLUNC1 expression reduces surface levels of the epithelial sodium channel (ENaC) in Xenopus laevis oocytes. Channels (Austin) 4(4):255-259
126. Garland AL et al (2013) Molecular basis for pH-dependent mucosal dehydration in cystic fibrosis airways. Proc Natl Acad Sci USA 110(40):15973-15978
127. Cho DY et al (2011) Acid and base secretion in freshly excised nasal tissue from cystic fibrosis patients with DeltaF508 mutation. Int Forum Allergy Rhinol 1(2):123-127
128. Tarran R, Redinbo MR (2014) Mammalian short palate lung and nasal epithelial clone 1 (SPLUNC1) in pH-dependent airway hydration. Int J Biochem Cell Biol 52:130-135
129. Di YP et al (2003) Molecular cloning and characterization of spurt, a human novel gene that is retinoic acid-inducible and encodes a secretory protein specific in upper respiratory tracts. J Biol Chem 278(2):1165-1173
130. Berdiev BK, Qadri YJ, Benos DJ (2009) Assessment of the CFTR and ENaC association. Mol BioSyst 5(2):123-127
131. Kunzelmann K, Schreiber R (2012) Airway epithelial cells - hyperabsorption in CF? Int J Biochem Cell Biol 44(8):1232-1235
132. + transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation. J Clin Invest 78(5):1245-1252
133. + currents by intracellular domains of the cystic fibrosis transmembrane conductance regulator. FEBS Lett 400(3):341-344
134. Stutts MJ et al (1995) CFTR as a cAMP-dependent regulator of sodium channels. Science 269(5225):847-850
135. Lazrak A et al (2011) Enhancement of alveolar epithelial sodium channel activity with decreased cystic fibrosis transmembrane conductance regulator expression in mouse lung. Am J Physiol Lung Cell Mol Physiol 301(4):L557-L567
136. Dransfield MT et al (2013) Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD. Chest 144(2):498-506
137. Vallet V et al (1997) An epithelial serine protease activates the amiloride-sensitive sodium channel. Nature 389(6651):607-610
138. + transport. Am J Physiol Lung Cell Mol Physiol 288(5):L813-L819
139. + hyperabsorption in cystic fibrosis airway epithelial cultures. J Physiol 592(Pt 23):5251-5268
140. Alli AA et al (2012) Cathepsin B is secreted apically from Xenopus 2F3 cells and cleaves the epithelial sodium channel (ENaC) to increase its activity. J Biol Chem 287(36):30073-30083
141. Butterworth MB et al (2012) Activation of the epithelial sodium channel (ENaC) by the alkaline protease from Pseudomonas aeruginosa. J Biol Chem 287(39):32556-32565
142. Hoenderdos K, Condliffe A (2013) The neutrophil in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 48(5):531-539
143. Borgerding M, Klus H (2005) Analysis of complex mixtures-cigarette smoke. Exp Toxicol Pathol 57(Suppl 1):43-73
144. Hoffmann D, Djordjevic MV, Hoffmann I (1997) The changing cigarette. Prev Med 26(4):427-434
145. Talhout R et al (2011) Hazardous compounds in tobacco smoke. Int J Environ Res Public Health 8(2):613-628
146. Scian MJ et al (2009) Chemical analysis of cigarette smoke particulate generated in the MSB-01 in vitro whole smoke exposure system. Inhal Toxicol 21(12):1040-1052
147. Fowles J, Dybing E (2003) Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob Control 12(4):424-430
148. Dye JA, Adler KB (1994) Effects of cigarette smoke on epithelial cells of the respiratory tract. Thorax 49(8):825-834
149. Yaghi A et al (2012) Ciliary beating is depressed in nasal cilia from chronic obstructive pulmonary disease subjects. Respir Med 106(8):1139-1147
150. Agius AM, Smallman LA, Pahor AL (1998) Age, smoking and nasal ciliary beat frequency. Clin Otolaryngol Allied Sci 23(3):227-230
151. Wyatt TA et al (2000) Acetaldehyde-stimulated PKC activity in airway epithelial cells treated with smoke extract from normal and smokeless cigarettes. Proc Soc Exp Biol Med 225(1):91-97
152. Tamashiro E et al (2009) Cigarette smoke exposure impairs respiratory epithelial ciliogenesis. Am J Rhinol Allergy 23(2):117-122
153. Lam HC et al (2013) Histone deacetylase 6-mediated selective autophagy regulates COPD-associated cilia dysfunction. J Clin Invest 123(12):5212-5230
154. Verra F et al (1995) Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokers. Am J Respir Crit Care Med 151(3 Pt 1):630-634
155. Auerbach O, Hammond EC, Garfinkel L (1979) Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 vs. 1970-1977. N Engl J Med 300(8):381-385
156. Leopold PL et al (2009) Smoking is associated with shortened airway cilia. PLoS One 4(12):e8157
157. Lungarella G, Fonzi L, Ermini G (1983) Abnormalities of bronchial cilia in patients with chronic bronchitis: an ultrastructural and quantitative analysis. Lung 161(3):147-156
158. Sisson JH et al (1994) Smoke and viral infection cause cilia loss detectable by bronchoalveolar lavage cytology and dynein ELISA. Am J Respir Crit Care Med 149(1):205-213
159. Kensler CJ, Battista SP (1963) Components of cigarette smoke with ciliary-depressant activity. Their selective removal by filters containing activated charcoal granules. N Engl J Med 269:1161-1166
160. Cantin AM et al (2006) Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers. Am J Respir Crit Care Med 173(10):1139-1144
161. Xu X et al (2015) Cigarette smoke exposure reveals a novel role for the MEK/ERK1/2 MAPK pathway in regulation of CFTR. Biochim Biophys Acta 1850(6):1224-1232. doi: 10.1016/j.bbagen.2015.02.004
162. 2+ release leads to cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. J Biol Chem 289(11):7671-7681
163. Gelman MS, Kannegaard ES, Kopito RR (2002) A principal role for the proteasome in endoplasmic reticulum-associated degradation of misfolded intracellular cystic fibrosis transmembrane conductance regulator. J Biol Chem 277(14):11709-11714
164. Johnston JA, Ward CL, Kopito RR (1998) Aggresomes: a cellular response to misfolded proteins. J Cell Biol 143(7):1883-1898
165. Sharma M et al (2004) Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes. J Cell Biol 164(6):923-933
166. Okiyoneda T et al (2010) Peripheral protein quality control removes unfolded CFTR from the plasma membrane. Science 329(5993):805-810
167. Younger JM et al (2006) Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator. Cell 126(3):571-582
168. Stevens JF, Maier CS (2008) Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol Nutr Food Res 52(1):7-25
169. Wang HT et al (2009) Mutagenicity and sequence specificity of acrolein-DNA adducts. Chem Res Toxicol 22(3):511-517
170. Phillips DH (2002) Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 23(12):1979-2004
171. Raju SV et al (2013) Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function. Am J Respir Crit Care Med 188(11):1321-1330
172. Moran AR et al (2014) Aqueous cigarette smoke extract induces a voltage-dependent inhibition of CFTR expressed in Xenopus oocytes. Am J Physiol Lung Cell Mol Physiol 306(3):L284-L291
173. Ballard ST et al (1999) CFTR involvement in chloride, bicarbonate, and liquid secretion by airway submucosal glands. Am J Physiol 277(4 Pt 1):L694-L699
174. Hug MJ, Tamada T, Bridges RJ (2003) CFTR and bicarbonate secretion by [correction of to] epithelial cells. News Physiol Sci 18:38-42
175. Pryor WA, Prier DG, Church DF (1983) Electron-spin resonance study of mainstream and sidestream cigarette smoke: nature of the free radicals in gas-phase smoke and in cigarette tar. Environ Health Perspect 47:345-355
176. Cantin AM et al (2006) Oxidant stress suppresses CFTR expression. Am J Physiol Cell Physiol 290(1):C262-C270
177. Hassan F et al (2012) MiR-101 and miR-144 regulate the expression of the CFTR chloride channel in the lung. PLoS One 7(11):e50837
178. Hassan F et al (2014) Accumulation of metals in GOLD4 COPD lungs is associated with decreased CFTR levels. Respir Res 15:69
179. Sloane PA et al (2012) A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease. PLoS One 7(6):e39809
180. Astrand AB et al (2015) Linking increased airway hydration, ciliary beating, and mucociliary clearance through ENaC inhibition. Am J Physiol Lung Cell Mol Physiol 308(1):L22-L32
181. Tyrrell J et al (2015) Roflumilast combined with adenosine increases mucosal hydration in human airway epithelial cultures after cigarette smoke exposure. Am J Physiol Lung Cell Mol Physiol 308:L10068-L11077
182. Andersen I et al (1974) Nasal clearance in monozygotic twins. Am Rev Respir Dis 110(3):301-305
183. Stanley PJ et al (1986) Effect of cigarette smoking on nasal mucociliary clearance and ciliary beat frequency. Thorax 41(7):519-523
184. Rubin BK et al (1992) Respiratory mucus from asymptomatic smokers is better hydrated and more easily cleared by mucociliary action. Am Rev Respir Dis 145(3):545-547
185. Hill DB et al (2014) A biophysical basis for mucus solids concentration as a candidate biomarker for airways disease. PLoS One 9(2):e87681
186. Baltimore RS, Christie CD, Smith GJ (1989) Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am Rev Respir Dis 140(6):1650-1661
187. Matsui H et al (2006) A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms. Proc Natl Acad Sci USA 103(48):18131-18136
188. Coles SJ, Levine LR, Reid L (1979) Hypersecretion of mucus glycoproteins in rat airways induced by tobacco smoke. Am J Pathol 94(3):459-472
189. Lamb D, Reid L (1969) Goblet cell increase in rat bronchial epithelium after exposure to cigarette and cigar tobacco smoke. Br Med J 1(5635):33-35
190. Basbaum C et al (1999) Control of mucin transcription by diverse injury-induced signaling pathways. Am J Respir Crit Care Med 160(5 Pt 2):S44-S48
191. Borchers MT, Carty MP, Leikauf GD (1999) Regulation of human airway mucins by acrolein and inflammatory mediators. Am J Physiol 276(4 Pt 1):L549-L555
192. Borchers MT, Wert SE, Leikauf GD (1998) Acrolein-induced MUC5ac expression in rat airways. Am J Physiol 274(4 Pt 1):L573-L581
193. Churg A, Cosio M, Wright JL (2008) Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am J Physiol Lung Cell Mol Physiol 294(4):L612-L631
194. Hughes JR (2007) Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective review. Nicotine Tob Res 9(3):329-339
195. Johnson JD et al (1990) Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans: a review. Crit Rev Toxicol 20(5):369-395
196. Liu C, Russell RM, Wang XD (2003) Exposing ferrets to cigarette smoke and a pharmacological dose of beta-carotene supplementation enhance in vitro retinoic acid catabolism in lungs via induction of cytochrome P450 enzymes. J Nutr 133(1):173-179
197. Hautamaki RD et al (1997) Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277(5334):2002-2004
198. Clarke LL et al (1994) Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr(-/-) mice. Proc Natl Acad Sci USA 91(2):479-483
199. Snouwaert JN et al (1992) An animal model for cystic fibrosis made by gene targeting. Science 257(5073):1083-1088
200. Majima Y et al (1983) Mucociliary clearance in chronic sinusitis: related human nasal clearance and in vitro bullfrog palate clearance. Biorheology 20(2):251-262
201. Mall MA (2008) Role of cilia, mucus, and airway surface liquid in mucociliary dysfunction: lessons from mouse models. J Aerosol Med Pulm Drug Deliv 21(1):13-24
202. + absorption produces cystic fibrosis-like lung disease in mice. Nat Med 10(5):487-493
203. Donaldson SH et al (2006) Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 354(3):241-250
204. Elkins MR et al (2006) A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 354(3):229-240
205. Taube C et al (2001) Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164(10 Pt 1):1810-1815
206. Angle N et al (1998) Hypertonic saline resuscitation diminishes lung injury by suppressing neutrophil activation after hemorrhagic shock. Shock 9(3):164-170
207. Lansdell KA et al (1998) Regulation of murine cystic fibrosis transmembrane conductance regulator Cl- channels expressed in Chinese hamster ovary cells. J Physiol 512(Pt 3):751-764
208. Gray MA et al (1990) Anion selectivity and block of the small-conductance chloride channel on pancreatic duct cells. Am J Physiol 259(5 Pt 1):C752-C761
209. Illek B et al (1999) Defective function of the cystic fibrosis-causing missense mutation G551D is recovered by genistein. Am J Physiol 277(4 Pt 1):C833-C839
210. Van Goor F et al (2009) Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc Natl Acad Sci USA 106(44):18825-18830
211. Dalemans W et al (1991) Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. Nature 354(6354):526-528
212. Van Goor F et al (2011) Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc Natl Acad Sci USA 108(46):18843-18848
213. Cholon DM et al (2014) Potentiator ivacaftor abrogates pharmacological correction of DeltaF508 CFTR in cystic fibrosis. Sci Transl Med 6(246):246ra96
214. Lambert JA et al (2013) Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis. Am J Respir Cell Mol Biol 50(3):549-558
215. Kew KM, Dias S, Cates CJ (2014) Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. Cochrane Database Syst Rev 3:CD010844
216. Boucher RC et al (1989) Chloride secretory response of cystic fibrosis human airway epithelia. Preservation of calcium but not protein kinase C- and A-dependent mechanisms. J Clin Invest 84(5):1424-1431
217. O'Riordan TG et al (2014) Acute hyperkalemia associated with inhalation of a potent ENaC antagonist: phase 1 trial of GS-9411. J Aerosol Med Pulm Drug Deliv 27(3):200-208
218. Kleyman TR, Cragoe EJ Jr (1988) The mechanism of action of amiloride. Semin Nephrol 8(3):242-248
219. Grasemann H, Ratjen F (2010) Emerging therapies for cystic fibrosis lung disease. Expert Opin Emerg Drugs 15(4):653-659
220. Chiu TF et al (1997) Rapid life-threatening hyperkalemia after addition of amiloride HCl/hydrochlorothiazide to angiotensin-converting enzyme inhibitor therapy. Ann Emerg Med 30(5):612-615
221. O'Riordan TG et al (2013) GS-5737, A novel epithelial sodium channel (ENaC) inhibitor: results of a Phase 1 Safety and pharmacodynamic (PK) Study. Pediatr Pulmonol S36:290
222. Terryah s et al (2014) A SPLUNC1-derived peptide reduces lung disease in scnn1b mice. Pediatr Pulmonol S38:285
223. Lee YO et al (2014) Multiple tobacco product use among adults in the United States: cigarettes, cigars, electronic cigarettes, hookah, smokeless tobacco, and snus. Prev Med 62:14-19
224. Benowitz NL, Goniewicz ML (2013) The regulatory challenge of electronic cigarettes. JAMA 310(7):685-686
225. McAuley TR et al (2012) Comparison of the effects of e-cigarette vapor and cigarette smoke on indoor air quality. Inhal Toxicol 24(12):850-857
226. Wu Q et al (2014) Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cells. PLoS One 9(9):e108342
227. Chen Y et al (2003) Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 278(19):17036-17043
228. Jensen RP et al (2015) Hidden formaldehyde in e-cigarette aerosols. N Engl J Med 372(4):392-394
229. Brown JE et al (2014) Candy flavorings in tobacco. N Engl J Med 370(23):2250-2252
230. Carpenter CM et al (2005) New cigarette brands with flavors that appeal to youth: tobacco marketing strategies. Health Aff (Millwood) 24(6):1601-1610
231. Regan AK, Dube SR, Arrazola R (2012) Smokeless and flavored tobacco products in the US: 2009 Styles survey results. Am J Prev Med 42(1):29-36
232. Willis DN et al (2011) Menthol attenuates respiratory irritation responses to multiple cigarette smoke irritants. FASEB J 25(12):4434-4444
233. Uhl GR et al (2011) Menthol preference among smokers: association with TRPA1 variants. Nicotine Tob Res 13(12):1311-1315
234. Shibamoto T (2014) Diacetyl: occurrence, analysis, and toxicity. J Agric Food Chem 62(18):4048-4053
235. Kreiss K et al (2002) Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant. N Engl J Med 347(5):330-338
236. McMillen R, Maduka J, Winickoff J (2012) Use of emerging tobacco products in the United States. J Environ Public Health 2012:989474
237. Rath JM et al (2012) Patterns of tobacco use and dual use in US young adults: the missing link between youth prevention and adult cessation. J Environ Public Health 2012:679134
238. Terchek JJ et al (2009) Measuring cigar use in adolescents: inclusion of a brand-specific item. Nicotine Tob Res 11(7):842-846
239. Hentschel J et al (2014) Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from cystic fibrosis patients during intravenous antibiotic treatment. BMC Pulm Med 14:82
240. Tsoumakidou M, Tzanakis N, Siafakas NM (2003) Induced sputum in the investigation of airway inflammation of COPD. Respir Med 97(8):863-871